-
-
-
-
-
-
-
TD Cowen Reiterates Hold Rating on Sanofi (SAN:FP) (SNY)
-
-
-
-
-
-
-
AstraZeneca says Fasenra misses main goal in COPD trial
-
-
-
-
-
-
-
Jefferies Downgrades Vigil Neuroscience Inc (VIGL) to Hold
-
-
-
-
-
-
-
Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting
-
-
-
-
-
-
-
Royalty Pharma plc (RPRX) to Acquire Royalty Interest in Sanofi’s (SNY) Frexalimab
-
-
-
-
-
-
-
Will this be the next obesity stock to be acquired?
-
-
-
-
-
-
-
Press Release: Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Provention Bio, Inc.
-
1,194,774 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

